119 related articles for article (PubMed ID: 18374571)
21. Evaluation of PepT1 (SLC15A1) Substrate Characteristics of Therapeutic Cyclic Peptides.
Bajraktari-Sylejmani G; von Linde T; Burhenne J; Haefeli WE; Sauter M; Weiss J
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015235
[TBL] [Abstract][Full Text] [Related]
22. Stable transfection of MDCK cells with epitope-tagged human PepT1.
Chu C; Okamoto CT; Hamm-Alvarez SF; Lee VH
Pharm Res; 2004 Nov; 21(11):1970-3. PubMed ID: 15587917
[TBL] [Abstract][Full Text] [Related]
23. The Role of N-Glycosylation in Maintaining the Transporter Activity and Expression of Human Oligopeptide Transporter 1.
Chan T; Lu X; Shams T; Zhu L; Murray M; Zhou F
Mol Pharm; 2016 Oct; 13(10):3449-3456. PubMed ID: 27547863
[TBL] [Abstract][Full Text] [Related]
24. Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs.
Våbenø J; Nielsen CU; Steffansen B; Lejon T; Sylte I; Jørgensen FS; Luthman K
Bioorg Med Chem; 2005 Mar; 13(6):1977-88. PubMed ID: 15727852
[TBL] [Abstract][Full Text] [Related]
25. Leptin transcriptionally enhances peptide transporter (hPepT1) expression and activity via the cAMP-response element-binding protein and Cdx2 transcription factors.
Nduati V; Yan Y; Dalmasso G; Driss A; Sitaraman S; Merlin D
J Biol Chem; 2007 Jan; 282(2):1359-73. PubMed ID: 16963449
[TBL] [Abstract][Full Text] [Related]
26. Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions.
Covitz KM; Amidon GL; Sadée W
Biochemistry; 1998 Oct; 37(43):15214-21. PubMed ID: 9790685
[TBL] [Abstract][Full Text] [Related]
27. Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.
Colas C; Masuda M; Sugio K; Miyauchi S; Hu Y; Smith DE; Schlessinger A
Mol Pharm; 2017 Dec; 14(12):4685-4693. PubMed ID: 29111754
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.
Thorn K; Andersen R; Christensen J; Jakobsen P; Nielsen CU; Steffansen B; Begtrup M
ChemMedChem; 2007 Apr; 2(4):479-87. PubMed ID: 17407174
[TBL] [Abstract][Full Text] [Related]
30. The intestinal H+/peptide symporter PEPT1: structure-affinity relationships.
Brandsch M; Knütter I; Leibach FH
Eur J Pharm Sci; 2004 Jan; 21(1):53-60. PubMed ID: 14706811
[TBL] [Abstract][Full Text] [Related]
31. Na+/H+ exchanger 3 affects transport property of H+/oligopeptide transporter 1.
Watanabe C; Kato Y; Ito S; Kubo Y; Sai Y; Tsuji A
Drug Metab Pharmacokinet; 2005 Dec; 20(6):443-51. PubMed ID: 16415530
[TBL] [Abstract][Full Text] [Related]
32. Photoinduced apoptosis using a peptide carrying a photosensitizer.
Watanabe K; Fujiwara H; Kitamatsu M; Ohtsuki T
Bioorg Med Chem Lett; 2016 Jul; 26(13):3115-3118. PubMed ID: 27165853
[TBL] [Abstract][Full Text] [Related]
33. Unraveling the kinetics and pharmacology of human PepT1 using solid supported membrane-based electrophysiology.
Körner A; Bazzone A; Wichert M; Barthmes M; Dondapati SK; Fertig N; Kubick S
Bioelectrochemistry; 2024 Feb; 155():108573. PubMed ID: 37748262
[TBL] [Abstract][Full Text] [Related]
34. Modeling of the intestinal peptide transporter hPepT1 and analysis of its transport capacities by docking and pharmacophore mapping.
Pedretti A; De Luca L; Marconi C; Negrisoli G; Aldini G; Vistoli G
ChemMedChem; 2008 Dec; 3(12):1913-21. PubMed ID: 18979492
[TBL] [Abstract][Full Text] [Related]
35. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.
Våbenø J; Nielsen CU; Ingebrigtsen T; Lejon T; Steffansen B; Luthman K
J Med Chem; 2004 Sep; 47(19):4755-65. PubMed ID: 15341490
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants of the human dipeptide transporter PEPT1.
Anderle P; Nielsen CU; Pinsonneault J; Krog PL; Brodin B; Sadée W
J Pharmacol Exp Ther; 2006 Feb; 316(2):636-46. PubMed ID: 16258023
[TBL] [Abstract][Full Text] [Related]
37. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
38. Affinity and translocation relationships via hPEPT1 of H-X aa-Ser-OH dipeptides: evaluation of H-Phe-Ser-OH as a pro-moiety for ibuprofen and benzoic acid prodrugs.
Omkvist DH; Trangbæk DJ; Mildon J; Paine JS; Brodin B; Begtrup M; Nielsen CU
Eur J Pharm Biopharm; 2011 Feb; 77(2):327-31. PubMed ID: 21147219
[TBL] [Abstract][Full Text] [Related]
39. In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides.
Flaten GE; Kottra G; Stensen W; Isaksen G; Karstad R; Svendsen JS; Daniel H; Svenson J
J Med Chem; 2011 Apr; 54(7):2422-32. PubMed ID: 21401113
[TBL] [Abstract][Full Text] [Related]
40. Protonation State of a Histidine Residue in Human Oligopeptide Transporter 1 (hPEPT1) Regulates hPEPT1-Mediated Efflux Activity.
Omori A; Fujisawa Y; Sasaki S; Shimono K; Kikukawa T; Miyauchi S
Biol Pharm Bull; 2021; 44(5):678-685. PubMed ID: 33952823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
